Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors

Blood

Volumn 100, Issue 13, 2002, Pages 4358-4366

  Marr, Kieren A ^a,b   Carter, Rachel A ^a,b   Boeckh, Michael ^a,b   Martin, Paul ^a,b   Corey, Lawrence ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CORTICOSTEROID; HLA ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; BONE MARROW; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VIRUS INFECTION;

EID: 0037114705     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1496     Document Type: Article

References (48)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310-350.
2. Wald A, Leisenring W, van Burik J, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997;175:1459-1466.
3. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant. 1997;19:801-808.
4. Marr K, Carter R, Crippa F, Wald A, Corey L. Epidemiology and outcome of mold infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909-917.
5. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. J Infect Dis. 1995;171:1545-1552.
6. Marr KA, Seidel K, Slavin M, et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial. Blood. 2000;96:2055-2061.
7. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962-968.
8. Li C, Greenberg P, Gilbert M, Goodrich J, Riddell S. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood. 1994;83:1971-1979.
9. Einsele H, Hebart H, Kauffmann-Schneider C, et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant. 2000;25:757-763.
10. Clift R, Buckner C, Thomas E, et al. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclosphosphamide and total body irradiation with busulfan and cyclosphosphamide. Blood. 1994;84:2036-2043.
11. Buckner C, Clift R, Appelbaum F, et al. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia. Bone Marrow Transplant. 1991;7(suppl 2):6-8.
12. Nash RA, Pineiro LA, Storb R, et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood. 1996;88:3634-3641.
13. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344:175-181.
14. Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L. Successful modification of a pp65 anti-genemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood. 1999;93:1781-1782.
15. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeniec marrow transplantation: A randomized double-blind study. Blood. 1996;88:4063-4071.
16. Ascioglu A, Rex J, DePauw B, et al. Defining opportunistic invasive fungal infections in immuno-compromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis. 2002;34:7-14.
17. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-828.
18. Sullivan K, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250-259.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Fisher L, vanBelle G. Biostatistics: A Methodology for the Health Sciences. New York, NY: John Wiley & Sons; 1993.
21. Baddley J, Stroud T, Salzman D, Pappas P. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001;32:1319-1324.
22. Grow W, Moreb J, Roque D, et al. Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 2002;29:15-19.
23. Ribaud P, Chastang C, Latge J, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis. 1999;28:322-330.
24. Saugier-Veber P, Devergie A, Sulahian A, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5 year retrospective study. Bone Marrow Transplant. 1993;12:121-124.
25. Iwen P, Reed E, Armitage J, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol. 1993;14:131-139.
26. Wingard J, Beals S, Santos G, Merz W, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant. 1987;2:175-181.
27. Winston D, Gale R, Meyer D, Young L, et al. Infectious complications of human bone marrow transplantation. Medicine. 1979;58:1-31.
28. Bensinger W, Buckner C, Anasetti C, et al. Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome. Blood. 1996;88:2787-2793.
29. Powles R, Mehta J, Kulkarni S, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial. Lancet. 2000;355:1231-1237.
30. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood. 2001;97:3380-3389.
31. Clark RA, Johnson FL, Klebanoff SJ, Thomas ED. Defective neutrophil chemotaxis in bone marrow transplant patients. J Clin Invest. 1976;58:22-31.
32. Cenci E, Mencacci A, Fe d'Ostiani C, et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis. 1998;178:1750-1760.
33. Cenci E, Perito S, Enssle K, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun. 1997;65:564-570.
34. deRepentigny L, Petitbois S, Boushira M, et al. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect Immun. 1993;61:3791-3802.
35. Remberger M, Ringden O, Blau IW, et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood. 2001;98:1739-1745.
36. Fauser AA, Basara N, Blau IW, Kiehl MG. A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): A single center study. Bone Marrow Transplant. 2000;25(suppl 2):S27-S31.
37. Blau IW, Basara N, Lentini G, et al. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: Results of a single-center study. Bone Marrow Transplant. 2001;27:27-33.
38. Husni R, Gordon S, Longworth D, et al. Cytomegalovirus is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998;26:753-755.
39. George MJ, Snydman DR, Werner BG, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Am J Med. 1997;103:106- 113.
40. Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis. 2000;181:309-316.
41. Morrison V, Haake R, Weisdorf D. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome. Am J Med. 1994;96:497-503.
42. Laursen A, Mogensen S, Andersen H, Andersen P, Ellermann-Erksen S. The impact of CMV on the repiratory burst of macrophages in response to Pneumocystis carinii. Clin Exp Immunol. 2001;123:239-246.
43. Lehner P, Wilkinson G. Cytomegalovirus: From evasion to suppression? Nat Immunol. 2001;2:993-994.
44. Broers AE, van Der Holt R, van Esser JW, et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood. 2000;95:2240-2245.
45. Nichols W, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among CMV seroponegative recipients of stem cell transplantation from seropositive donors (D+/R-): Evidence for "indirect" effects of primary CMV infection. J Infect Dis. 2002;185:273-282.
46. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: Risk factors, response to antiviral therapy, and effect on transplant outcome. Blood. 2001;98:573-578.
47. Franke-Ullmann G, Pfortner C, Walter P, et al. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J Immunol. 1995;154:268-280.
48. Perfect J, Cox G, Lee J, et al. The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824-1833.